2054. Deputy Ken O'Flynn asked the Minister for Health the number of patients funded under the treatment abroad scheme for gender affirmation surgery in each of the years from 2020 to 2025 and to-date in 2026. [20088/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn .
3,835 questions match, newest first.
2055. Deputy Ken O'Flynn asked the Minister for Health the total expenditure incurred under the treatment abroad scheme for gender affirmation surgery in each of the years from 2020 to 2025 and to-date in 2026, including surgery, travel, accommodation and associated medical costs. [20089/26]
2056. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE collects outcome data, complication rates, or patient follow-up information for gender affirmation surgeries funded abroad under the treatment abroad scheme. [20090/26]
2057. Deputy Ken O'Flynn asked the Minister for Health whether any clinical governance framework exists for monitoring referrals by multidisciplinary teams recommending gender affirmation surgery funded under the treatment abroad scheme. [20091/26]
2060. Deputy Ken O'Flynn asked the Minister for Health the total expenditure by the Health Service Executive under the treatment abroad scheme in respect of gender affirmation surgeries undertaken outside the State in each year from 2020 to 2025 inclusive; the number of individual procedures funded in each year; and the average cost per procedure in each of those years. [20121/26]
2061. Deputy Ken O'Flynn asked the Minister for Health the countries and healthcare providers in which gender affirmation surgeries funded under the Treatment Abroad Scheme have been carried out since 2020; the number of procedures funded in each jurisdiction; and whether the Department maintains a list of approved hospitals or surgical centres for such treatments. [20122/26]
2062. Deputy Ken O'Flynn asked the Minister for Health the policy or governance framework under which applications for gender affirmation surgery abroad are assessed under the Treatment Abroad Scheme; the number of applications received and approved in each year since 2020; and the clinical or administrative authority responsible for granting final approval for such funding. [20123/26]
2063. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the Health Service Executive records clinical outcomes, complications, or follow-up care requirements for patients who receive gender affirmation surgery abroad funded under the treatment abroad scheme; and if so, the oversight mechanisms in place to monitor patient outcomes and long-term healthcare impacts. [20124/26]
2064. Deputy Ken O'Flynn asked the Minister for Health whether the Department has conducted or commissioned any review, audit, or policy assessment of the use of the treatment abroad scheme to fund gender affirmation surgeries outside the State since 2020; and if not, whether she intends to commission such a review. [20125/26]
2067. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the Health Service Executive records the time required to approve recruitment requests submitted under the processes established by CEO Memo 09892 of 4 October 2023 and CEO Memo 10885 of 26 February 2024; the average time taken from submission to decision in each year since 2023; and whether clearance timeline key performance indicators …
2068. Deputy Ken O'Flynn asked the Minister for Health the number of recruitment approval requests submitted to the National Director of HR under CEO Memo 10885 in 2024 and 2025; the number approved, refused, withdrawn or returned for further information; and the average time taken to issue a decision in each case. [20139/26]
2069. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the Health Service Executive has undertaken any review, analysis or briefing assessing the operational impact of recruitment control measures introduced under CEO Memo 09892 of 4 October 2023 and CEO Memo 10885 of 26 February 2024, including impacts on vacancy persistence, recruitment delays and service delivery; and whether she will pub…
2070. Deputy Ken O'Flynn asked the Minister for Health whether her Department monitors the number of vacant posts which remain unfilled due to recruitment approval processes introduced under CEO Memo 09892 and CEO Memo 10885; the number of such posts in each health region and national service area; and whether this information is reported to her Department on a routine basis. [20141/26]
2071. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed whether the recruitment control measures introduced under CEO Memo 09892 and CEO Memo 10885 have contributed to delays in filling clinical or frontline posts, including those within hospital services, community health services and the National Ambulance Service; and if she will provide details of any such assessment. [20142/26]
2077. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the Health Service Executive maintains any national system for monitoring clinical outcomes, complications, or long-term follow-up in respect of children and adolescents from Ireland who receive gender-related medical treatment abroad under the treatment abroad scheme or any related referral pathway; if so, the governance arrangements fo…
2082. Deputy Ken O'Flynn asked the Minister for Health the current clinical governance framework applying to gender identity healthcare services provided to children and adolescents in Ireland pending completion of the updated national model of care; whether a national dataset, audit framework or outcome monitoring system is currently in place for these services; and the safeguards and oversight mechanisms which oper…
2093. Deputy Ken O'Flynn asked the Minister for Health whether her Department has approved or mandated the establishment of a national dataset for the purposes of planning, governance, oversight and evaluation of gender identity healthcare services provided to children and adolescents within the public health system; if not, whether such a dataset will be introduced; and the timeframe for its implementation. [20261/2…
2094. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives any aggregated national data from the Health Service Executive regarding the number of children and adolescents referred to gender identity services each year; if so, the annual totals for each of the years 2018 to 2025; and if she will make a statement on the matter. [20262/26]
2095. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical audit, patient safety review or governance evaluation has been undertaken since 2020 in respect of gender identity services provided to children and adolescents within the public health system; if so, to provide the dates and scope of such reviews; and if she will make a statement on the matter. [20263/26]
2096. Deputy Ken O'Flynn asked the Minister for Health whether the Department has received the report of the expert group established by the Health Service Executive to consider the implications of the final Cass Review for gender healthcare services in Ireland; if so, the date on which the report was received; and whether she intends to publish the report. [20264/26]
2097. Deputy Ken O'Flynn asked the Minister for Health the formal national clinical governance framework that currently applies to gender identity healthcare services provided to minors pending completion of the updated national model of care; and the specific safeguarding standards required under that framework. [20265/26]
2098. Deputy Ken O'Flynn asked the Minister for Health whether her Department has issued any policy direction, guidance or instruction to the Health Service Executive following publication of the final Cass Review regarding the provision of gender identity healthcare services to children and adolescents in Ireland. [20266/26]
2100. Deputy Ken O'Flynn asked the Minister for Health the formal methodological framework used by her Department when evaluating international clinical guidance prior to incorporation into national healthcare policy; and whether such a methodology was applied in respect of international guidance on gender identity healthcare between 2018 and 2023. [20274/26]
2101. Deputy Ken O'Flynn asked the Minister for Health the date on which the Health Service Executive completed its review of the Cass Review; whether the completed review has been submitted to her Department; the date on which her Department received the document, if applicable; whether she intends to publish the review; and if publication is not intended, the reason the document will not be placed in the public dom…
2102. Deputy Ken O'Flynn asked the Minister for Health the terms of reference issued for the Health Service Executive review of the Cass Review; the names or professional roles of the clinical experts who conducted that review; the governance structure under which the work was undertaken; and whether the review included consideration of safeguarding and clinical risk factors affecting children and adolescents. [20289…